XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements Of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Oct. 01, 2022
Sep. 30, 2023
Oct. 01, 2022
Net Sales $ 888,239 $ 993,828 $ 2,711,635 $ 2,335,963
Cost of sales 521,165 622,157 1,558,710 1,344,075
Gross profit 367,074 371,671 1,152,925 991,888
Selling, general and administrative expenses 116,051 226,446 431,514 404,239
Engineering, research and development expenses 66,810 64,990 209,746 160,953
Amortization of intangible assets 51,239 65,346 163,493 90,491
Impairment of goodwill 15,913   104,785 0
Gain on termination of alliance agreement 0 0 (154,754) 0
Operating income 117,061 14,889 398,141 336,205
Interest expense 77,820 84,150 244,874 129,027
Interest income (2,226) (1,395) (5,854) (2,065)
Other expense, net 10,243 12,852 13,309 27,373
Income (loss) before income tax (benefit) expense 31,224 (80,718) 145,812 181,870
Income tax (benefit) expense (2,127) (7,015) 2,851 30,377
Equity in net loss of affiliates 139 0 269 0
Net income (loss) $ 33,212 $ (73,703) $ 142,692 $ 151,493
Basic earnings (loss) per common share $ 0.22 $ (0.50) $ 0.95 $ 1.08
Diluted earnings (loss) per common share $ 0.22 $ (0.50) $ 0.95 $ 1.08
Weighted shares outstanding:        
Basic 150,127 148,570 149,793 140,045
Diluted 151,229 148,570 150,816 140,892